Measles Vaccine
Measles catch-up and follow-up campaigns in Afghanistan are cost effective
Published in Medical Letter on the CDC and FDA, August 6th, 2006
According to a report from an international team, "This paper assesses the cost-effectiveness of, and the return on the investment in, the 2002 catch-up and the 2003 follow-up measles campaigns in Afghanistan from the perspective of the donor."
"The catch-up campaign targeted nearly 12 million children aged between six months and 12 years, while the follow-up campaign targeted over five million children aged between 9 and 59 months," explained %." Maya Vijayaraghavan at the U.S. Centers for Disease Control and Prevention and collaborators in the U.S., Switzerland, and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Anthrax Vaccine
No link was found between anthrax vaccination and risk of optic neuritis - Brainerd Diarrhea
Outbreak of Brainerd diarrhea was linked to restaurant in Texas - Breast Cancer
Rho GTPase regulator promotes breast cancer cell invasiveness - Pituitary Cancer Risk Factors
Atypical antipsychotics are linked to pituitary tumors - Rotavirus Epidemiology
Rotavirus is important cause of diarrhea-related hospitalization in U.S. children - Addiction Medicine
Inappropriate vasopressin secretion was found in ecstasy-using 'clubbers' - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
